Factors associated with inappropriate inpatient prescribing of acid-suppressive therapy

International Journal of Pharmacy Practice

Volumn 17, Issue 1, 2009, Pages 73-75

  Palkovic, Lindsay B ^a,b   Coley, Kim C ^c   Sokos, Denise R ^c  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acid suppressive therapy; Histamine2 receptor antagonists; Medication overuse, Proton pump inhibitors

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AGE; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INDICATION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INTERNAL MEDICINE; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MEDICATION ERROR; PHARMACEUTICAL CARE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ACADEMIC MEDICAL CENTERS; AGE FACTORS; ANTACIDS; ANTICOAGULANTS; FIBROSIS; HISTAMINE H2 ANTAGONISTS; HUMANS; INTERNAL MEDICINE; LENGTH OF STAY; LOGISTIC MODELS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES;

EID: 59149091492     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.17.1.0011     Document Type: Article

References (10)

1. Nardino RJ et al. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-3122.
2. Pham CQD et al. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother 2006; 40(7): 1261-1266.
3. Product information. Prevacid (lansoprazole). Lake Forest, IL: TAP Pharmaceuticals, 2006.
4. Product information. Pepcid (famotidine). Whitehouse Station, NJ: Merck & Co., 2006.
5. Fass R et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42-49.
6. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895.
7. Barkun A et al. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-857.
8. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol 2006; 101: 2200-2205.
9. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999; 56: 347-379.
10. Lanza FL et al. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 1998; 93: 2037-2046.